Nature CommunicationsGenomicsPeer-reviewed journal article
CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations
Ida HöijeriD, Anastasia EmmanouilidouiD, Rebecka ÖstlundiD, Robin van SchendeliD, Selma Bozorgpana, Marcel TijstermaniD, Lars FeukiD, Ulf B GyllensteniD, Marcel den HoediD, Adam AmeuriD
- Citations
- 188
- FWCI
- 12.73
- Field percentile
- top 1%
Abstract
To investigate the extent and distribution of unintended mutations induced by CRISPR-Cas9 in vivo, we edited the genome of fertilized zebrafish eggs and investigated DNA from >1100 larvae, juvenile and adult fish in the F0 and F1 generations. Four guide RNAs (gRNAs) were used, selected from 23 gRNAs with high on-target efficiency in vivo in previous functional experiments. CRISPR-Cas9 outcomes were analyzed by long-read sequencing of on-target sites and off-target sites detected in vitro. In founder larvae, on-target editing of the four gRNAs was 93-97% efficient, and three sites across two gRNAs were identified with in vivo off-target editing. Seven percent of the CRISPR-Cas9 editing outcomes correspond to structural variants (SVs), i.e., insertions and deletions [≥]50 bp. The adult founder fish displayed a mosaic pattern of editing events in somatic and germ cells. The F1 generation contained high levels of genome editing, with all alleles of 46 examined F1 juvenile fish affected by on-target mutations, including four cases of SVs. In addition, 26% of the juvenile F1 fish (n=12) carried off-target mutations. These CRISPR-induced off-target mutations in F1 fish were successfully validated in pooled larvae from the same founder parents. In conclusion, we demonstrate that large SVs and off-target mutations can be introduced in vivo and passed through the germline to the F1 generation. The results have important consequences for the use of CRISPR-Cas9 in clinical applications, where pre-testing for off-target activity and SVs on patient material is advisable to reduce the risk of unanticipated effects with potentially large implications.
- organism: zebrafish
- assay: whole-genome sequencing
- research focus: variant calling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Analysis of single nucleotide variants in CRISPR-Cas9 edited zebrafish embryos shows no evidence of off-target inflation
Marie R. Mooney, Erica E. Davis, Nicholas Katsanis·Frontiers in GeneticsPeer-reviewed·Oct 11, 2019
- Accurate characterization of CRISPR-Cas9 genome editing outcomes and mosaicism with near-perfect long reads
Ida Höijer, Robin van Schendel, … Adam Ameur·bioRxiv·Sep 8, 2025
- In vivo CRISPR-Cas gene editing with no detectable genome-wide off-target mutations
Pınar Akçakaya, Maggie L. Bobbin, … J. Keith Joung·NaturePeer-reviewed·Sep 1, 2018
- Frequent loss-of-heterozygosity in CRISPR-Cas9-edited early human embryos
Gregorio Alanis‐Lobato, Jasmin Zohren, … Kathy K. Niakan·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 9, 2021
- "Unexpected mutations after CRISPR-Cas9 editing in vivo" are most likely pre-existing sequence variants and not nuclease-induced mutations
Caleb A. Lareau, Kendell Clement, … Luca Pinello·Nature MethodsPeer-reviewed·Mar 30, 2018
- Corrigendum and follow-up: Whole genome sequencing of multiple CRISPR-edited mouse lines suggests no excess mutations.
Kellie A. Schaefer, Benjamin W Darbro, … Vinit B. Mahajan·bioRxiv·Mar 26, 2018